# Top 50 Biotech Startup Investors in Israel in June 2026

## Trendlines Group
- Type: VC Fund
- Location: Misgav, HaZafon, Israel
- Relevant deals: 17
- Stages: Seed, Series A
- Focus: Health Care, Biotechnology, Medical Device

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

## Pontifax
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 16
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

## Israel Innovation Authority
- Type: VC Fund
- Location: Jerusalem, Yerushalayim, Israel
- Relevant deals: 12
- Stages: Grant, Seed, Pre-Seed
- Focus: Health Care, Biotechnology, Medical Device

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

## OurCrowd
- Type: VC Fund
- Location: Jerusalem, Yerushalayim, Israel
- Relevant deals: 10
- Stages: Series B, Series A, Seed
- Focus: Software, Artificial Intelligence, Health Care

Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.

## aMoon Fund
- Type: VC Fund
- Location: Ra'anana, HaMerkaz, Israel
- Relevant deals: 7
- Stages: Series B, Series A, Series C
- Focus: Health Care, Biotechnology, Medical

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

## OrbiMed
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 7
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Medical

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

## Arkin Holdings
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 6
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Medical

Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more

## Docor International Management
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 6
- Stages: Series C, Series A
- Focus: Health Care, Biotechnology, 3D Technology

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

## ZORA Ventures
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 5
- Stages: Seed, Series A, Convertible Note
- Focus: Health Care, Biotechnology, Internet

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

## HBL Hadasit Bio Holdings
- Type: VC Fund
- Location: Jerusalem, Yerushalayim, Israel
- Relevant deals: 5
- Stages: Series A, Series B
- Focus: Biotechnology, Medical, Health Care

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

## iAngels
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Software, Artificial Intelligence, Financial Services

Invest in groundbreaking startups with iAngels. Discovercutting-edge technology and join a community of forward-thinking investors shapingthe future of entrepreneurship.

## New York Ventures
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Health Care, Biotechnology, Software

New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the RegionalEconomic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.

## Takeda Ventures
- Type: VC Fund
- Location: San Diego, California, United States
- Relevant deals: 4
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Therapeutics

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA.  As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

## Grove Ventures
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Artificial Intelligence, Software, Machine Learning

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...

## Johnson & Johnson Robotics and Digital Solutions
- Type: VC Fund
- Location: New Brunswick, New Jersey, United States
- Relevant deals: 4
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Healthcare innovation wherever it originates.

## Integra Holdings
- Type: VC Fund
- Location: Wallisellen, Zurich, Switzerland
- Relevant deals: 4
- Stages: Seed, Series B, Series F
- Focus: Biotechnology, Pharmaceutical, Life Science

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies.  
Our golden eggs    
Ayana Pharma
A late stage company with

## Sapir Venture Partners
- Type: VC Fund
- Relevant deals: 4
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Biotechnology, Machine Learning

Early Stage VC

## Clal Biotechnology Industries
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 4
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).

## Ziegler Meditech Equity Partners
- Type: VC Fund
- Location: Milwaukee, Wisconsin, United States
- Relevant deals: 3
- Stages: Series C, Series E, Series F
- Focus: Health Care, Biotechnology, Mobile

Ziegler is a privately held investment bank, capital markets and proprietary investments firm.

## fresh.fund
- Type: VC Fund
- Location: Jerusalem, Yerushalayim, Israel
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Artificial Intelligence, Software

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio.
It's never too early to have a conversation about your startup.

## Binder & Partners Ventures
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Information Technology, Computer

Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.

## Milk & Honey Ventures
- Type: VC Fund
- Relevant deals: 3
- Stages: Pre-Seed, Seed, Series A
- Focus: Biotechnology, Food and Beverage, Nutrition

Tel-Aviv based investment firm, focused on the effective acceleration of disruptive New Protein technologies

## EIT Food
- Type: VC Fund
- Location: Belgium, Wisconsin, United States
- Relevant deals: 3
- Stages: Grant, Seed
- Focus: Food and Beverage, Biotechnology, Food Processing

EIT Food is a European Knowledge and Innovation Community (KIC), which was set up to transform our food ecosystem. By connecting consumers with businesses, start-ups, researchers and students from around Europe, EIT Food supports innovative and economically sustainable initiatives which improve our health, our access to quality food, and our environment

## Cancer Focus Fund
- Type: VC Fund
- Location: Shreveport, Louisiana, United States
- Relevant deals: 3
- Stages: Series A, Seed
- Focus: Biotechnology, Medical, Health Care

Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.

## FutuRx
- Type: VC Fund
- Location: Ness Ziona, HaMerkaz, Israel
- Relevant deals: 3
- Stages: Seed
- Focus: Biotechnology, Life Science, Biopharma

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

## Consensus Business Group
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Health Care, Medical Device, Medical

Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.

## GlenRock Israel
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Seed, Series B, Series A
- Focus: Software, Cyber Security, Health Care

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns. 

## SciSparc
- Type: VC Fund
- Location: Giv'atayim, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Corporate Round
- Focus: Pharmaceutical, Cannabis, Biopharma

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.

## Pitango VC
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Software, Health Care, Information Technology

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

## Millenium Food-Tech
- Type: VC Fund
- Relevant deals: 3
- Stages: Seed, Series A, Convertible Note
- Focus: Food and Beverage, Manufacturing, Retail

Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.

## Nevateam Partners
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: AgTech, SaaS, Farming

NevaTeam Partners is an Agri-Food Tech ESG Impact driven Fund with world-class knowledge and expertise that specializes in identifying and investing in cutting-edge companies and technologies, contributing to the streamlining and increase in world food production in a sustainable way.

## Siddhi Capital
- Type: VC Fund
- Location: Cherry Hill, New Jersey, United States
- Relevant deals: 3
- Stages: Seed, Series A, Series B
- Focus: Food and Beverage, Biotechnology, Nutrition

Siddhi Capital is the growth equity partner for convention-crushing food and beverage companies. 

## Accelmed
- Type: VC Fund
- Location: Aventura, Florida, United States
- Relevant deals: 3
- Stages: Series D, Series A
- Focus: Health Care, Medical Device, Medical

Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.

## Welltech Ventures
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Seed, Pre-Seed
- Focus: mHealth, Health Care, Biotechnology

Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.

## DSM Venturing
- Type: VC Fund
- Location: Heerlen, Limburg, The Netherlands
- Relevant deals: 3
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Manufacturing

Innovators in nutrition, health, and beauty. Together, we bring progress to life by combining the essential, the desirable, and the sustainable. 

## Office of the Chief Scientist
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Seed
- Focus: Health Care, Biotechnology, Hardware

The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.

## Yossi Ackerman
- Type: Angel
- Relevant deals: 3
- Stages: Seed, Angel, Series A
- Focus: Apps, Local, Mobile

Joseph Ackerman, also known as Yossi, served as the Chief Executive Officer and President of Elbit Systems Ltd., the holding company of Elbit Security Systems Ltd. and Harpia Sistemas S.A. from 1996 to March 31, 2013. From 1994 to 1996, Joseph Ackerman served as Senior Vice President and General Manager of Elbit Ltd.'s Defense Systems Division(EDS.). He joined Elbit Ltd. in 1982 and held various management positions, including General Manager of EFW, Senior Vice President of Operations Group, Vice President of Operations and Vice President of Advanced Battlefield Systems. He serves as the Chairman of MediGuide Ltd. He served as the Chairman of Elbit Systems EW and SIGINT - Elisra Ltd. and Elbit Systems Ltd. He served as the Chairman of Tadiran Communications Ltd. since August 2005. He served as the Chairman of Elbit Systems Ltd. from 1996 to 2004. He served as the Vice Chairman of Elbit Systems Ltd. from April 1, 2013 to November 19, 2013. He serves as a Director of Imagesat International N.v. He served as a Director of Elbit Systems Ltd., the holding company of Elbit Systems EW and SIGINT - Elisra Ltd. from 1996 to 2004. Joseph Ackerman holds a Bachelor of Science degree in Aeronautical Engineering from the Israel Institute of Technology (the Technion).

## Good Seed Ventures
- Type: VC Fund
- Location: Rheine, Nordrhein-Westfalen, Germany
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: Food and Beverage, Food Processing, Biotechnology

Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.

## Fortissimo Capital
- Type: VC Fund
- Location: Rosh Ha'ayin, HaMerkaz, Israel
- Relevant deals: 2
- Stages: Series B, Series C
- Focus: Manufacturing, Software, Information Technology

Fortissimo Capital is a growth equity fund that supports companies focusing on technology industries. They partner with strong management teams to invest in growth and transformation. They invest in public and private technology companies at inflection points and in special situations, where their experience and long term strategic commitment canmaximize value.It was founded in 2004 and headquartered in HaMerkaz, Israel.

## Ocean Azul Partners
- Type: VC Fund
- Location: Miami, Florida, United States
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Information Technology, Artificial Intelligence

We are an early stage venture capital fund passionate about helping entrepreneurs bring innovative solutions to market.

## Impact First Investments
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Health Care, mHealth, Medical Device

Impact First Investments is the first Israeli impact venture capital fund with the trifold aim to bolster Israeli technology, to build global social impact, and to obtain market-rate returns.Impact investing is dynamic. It’s a web of enterprise, venture, and ingenuity with the goal to do good and do well. At Impact First, they capitalize onboldness.Technology has the ability to both address challenges and scale solutions. They capitalize and advance this interest. They recognize this growing potential of doing good and doing well, and combined with experience in Israeli high tech, they have the ability to address global social challenges by supporting social tech startups.

## Tyson Ventures
- Type: VC Fund
- Location: Springdale, Arkansas, United States
- Relevant deals: 2
- Stages: Series B, Seed
- Focus: Food and Beverage, Biotechnology, Software

Tyson Ventures is the investment arm of Tyson Foods. We aim to be the strategic partner of choice for disruptive innovators transforming the food industry, and provide sustainable nutrition to a growing global population. Our current areas of interest focus on emerging proteins, technology enablers and sustainability. Let’s build the future offood... together.

## RMGP Biopharma Investment Fund
- Type: VC Fund
- Relevant deals: 2
- Stages: Seed, Series B
- Focus: Biotechnology, Biopharma, Health Care

RMGP Biopharma Investment Fund is an investment Fund

## Amplifyher Ventures
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: Health Care, E-Commerce, Fashion

Venture capital fund investing in female founders and women leaders

## Howard Morgan
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, Artificial Intelligence, Health Care

Howard Morgan is currently the Chairman of B Capital. He co-founded First Round Capital with Josh Kopelman as the first professional Seed Stage Fund, where he remains Senior Advisor.  Prior to First Round, Howard helped found Idealab with Bill Gross, and served as President of Renaissance Technologies, which he co-founded with Jim Simons.  Prior tohis move into the business of technology, Howard served as a professor at the Wharton School and the Moore School, both at the University of Pennsylvania, as well as at Cornell University.  He is also an Executive Fellow at UC Berkeley.
Howard’s research on user interface technology and the optimization of computer networks was critical to bringing the ARPAnet to Philadelphia in the 1970s. Through this early internet participation, he helped corporate and government agencies use technology to improve the efficiency of both large and small organizations. He also has deep experience with very large databases, and served as the first Editor of the ACM Transactions on Database Systems Journal.
Throughout his career, Howard has sought out great people and nurtured them so that they could realize their dreams. His mentees have included both PhD students researching a key topic, and early stage entrepreneurs building companies and taking them from seed stage through initial public offerings. He currently serves as a Director of Idealab, and he is on the board of several non-profits including Cold Spring Harbor Laboratories and Math For America. He has also served on a number of public company Boards, including Franklin Electronic Publishers and Internet Brands, Inc. He was CEO of Kentek and Franklin during various turnover or transitional periods and in 1997 he was named Delaware Valley Entrepreneur of the Year. Howard is a respected author and a frequent speaker at major industry conferences.
Howard received a PhD in Operations Research from Cornell University in 1968, and a BS in Physics from City College of the City University of New York in 1965.

## CE Ventures (CEIIF)
- Type: VC Fund
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 2
- Stages: Series B, Series A, Series C
- Focus: Software, Analytics, Big Data

CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.

## Agrinnovation
- Type: VC Fund
- Location: Jerusalem, Yerushalayim, Israel
- Relevant deals: 2
- Stages: Seed
- Focus: Biotechnology, Food Processing, SaaS

Agrinnovation is a one-of-a-kind investment fund. While remaining steadfastly independent in all business related issues, the fund has exclusive access and first commercial rights to invest in IP developed in the Faculty of Agriculture, Food and Environment of Israel’s elite academic institution, the Hebrew University of Jerusalem. This exclusivestatus grants us extra time to perform a deeper probe into the new technologies and to bring them from lab to market more swiftly, securely and freely.Backed by an experienced SAB, they work closely with HU scientists and researchers to thoroughly test the technological applicability, scalability and patentability of each breakthrough. Once the technology has proven viable, together with their accomplished Commercial Advisory Board, they meticulously research and test the commercial feasibility of the project before investing and turning it into commercial start-up.Agrinnovation was founded in 2015 by Yissum, the distinguished technology transfer company of the Hebrew University of Jerusalem with over 2 billion dollars in annual sales. Shareholders also include VBS Agri Ventures Pty Ltd., Provident Fund of The Hebrew University of Jerusalem Ltd. and Kingenta Livnat Agriscience Development. The fund is managed by Dr. Ido Schechter, who brings with him decades of business experience in hi-tech and agritech.

## S2G Investments
- Type: VC Fund
- Location: Chicago, Illinois, United States
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Agriculture, Food and Beverage, Biotechnology

S2G Ventures is is a multi-stage venture fund investing in food and agriculture.  We're harnessing the power of food innovation to create better outcomes for people and the planet.

## NFX Bio
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 2
- Stages: Seed
- Focus: Biotechnology, Therapeutics, Medical

NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.Led by Omri Amirav Drory, a venture partner with NFX, who founded Genome Compiler, it helps scientists learn to be founders and guides biology companies with information technology to be a critical distinction with massiveimplications.

## M Ventures
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co